A detailed history of Cannell & Co. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cannell & Co. holds 315,918 shares of MRK stock, worth $35.9 Million. This represents 1.14% of its overall portfolio holdings.

Number of Shares
315,918
Previous 313,603 0.74%
Holding current value
$35.9 Million
Previous $32.3 Million 6.68%
% of portfolio
1.14%
Previous 1.14%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

BUY
$100.18 - $109.02 $231,916 - $252,381
2,315 Added 0.74%
315,918 $34.4 Million
Q3 2023

Nov 14, 2023

SELL
$102.95 - $114.33 $503,013 - $558,616
-4,886 Reduced 1.53%
313,603 $32.3 Million
Q2 2023

Aug 09, 2023

SELL
$108.61 - $118.38 $1.32 Million - $1.44 Million
-12,182 Reduced 3.68%
318,489 $36.8 Million
Q1 2023

May 08, 2023

SELL
$102.94 - $114.86 $634,728 - $708,226
-6,166 Reduced 1.83%
330,671 $35.2 Million
Q4 2022

Feb 03, 2023

SELL
$87.44 - $112.11 $58,147 - $74,553
-665 Reduced 0.2%
336,837 $37.4 Million
Q3 2022

Nov 02, 2022

SELL
$84.53 - $94.96 $80,303 - $90,212
-950 Reduced 0.28%
337,502 $29.1 Million
Q2 2022

Aug 08, 2022

SELL
$83.49 - $94.64 $435,066 - $493,169
-5,211 Reduced 1.52%
338,452 $30.9 Million
Q1 2022

May 10, 2022

BUY
$73.51 - $82.4 $115,043 - $128,956
1,565 Added 0.46%
343,663 $28.2 Million
Q4 2021

Feb 09, 2022

BUY
$72.28 - $90.54 $893,380 - $1.12 Million
12,360 Added 3.75%
342,098 $26.2 Million
Q3 2021

Nov 10, 2021

BUY
$71.68 - $78.83 $2.35 Million - $2.58 Million
32,770 Added 11.03%
329,738 $24.8 Million
Q2 2021

Aug 09, 2021

BUY
$70.31 - $77.77 $5.51 Million - $6.09 Million
78,297 Added 35.81%
296,968 $23.1 Million
Q1 2021

May 07, 2021

SELL
$68.86 - $81.11 $224,896 - $264,905
-3,266 Reduced 1.47%
218,671 $16.9 Million
Q4 2020

Feb 11, 2021

BUY
$71.77 - $79.65 $2.23 Million - $2.47 Million
31,039 Added 16.26%
221,937 $18.2 Million
Q3 2020

Nov 12, 2020

SELL
$73.18 - $82.95 $676,256 - $766,540
-9,241 Reduced 4.62%
190,898 $15.8 Million
Q2 2020

Aug 07, 2020

SELL
$70.42 - $80.13 $6.62 Million - $7.53 Million
-93,991 Reduced 31.96%
200,139 $15.5 Million
Q1 2020

May 05, 2020

SELL
$63.36 - $87.82 $355,069 - $492,143
-5,604 Reduced 1.87%
294,130 $22.6 Million
Q4 2019

Feb 10, 2020

BUY
$77.58 - $87.54 $1.27 Million - $1.43 Million
16,362 Added 5.77%
299,734 $27.3 Million
Q3 2019

Nov 12, 2019

BUY
$76.08 - $82.93 $227,022 - $247,463
2,984 Added 1.06%
283,372 $23.9 Million
Q2 2019

Aug 12, 2019

BUY
$69.84 - $81.59 $932,224 - $1.09 Million
13,348 Added 5.0%
280,388 $23.5 Million
Q1 2019

May 14, 2019

SELL
$69.58 - $79.36 $3.93 Million - $4.48 Million
-56,439 Reduced 17.45%
267,040 $22.2 Million
Q4 2018

Feb 11, 2019

SELL
$65.24 - $75.71 $357,710 - $415,117
-5,483 Reduced 1.67%
323,479 $24.7 Million
Q3 2018

Nov 05, 2018

BUY
$57.69 - $67.84 $2.89 Million - $3.39 Million
50,017 Added 17.93%
328,962 $23.3 Million
Q2 2018

Aug 06, 2018

BUY
$50.83 - $59.72 $3.19 Million - $3.74 Million
62,675 Added 28.98%
278,945 $16.9 Million
Q1 2018

May 09, 2018

SELL
$50.96 - $59.23 $324,666 - $377,354
-6,371 Reduced 2.86%
216,270 $11.8 Million
Q4 2017

Feb 13, 2018

BUY
$51.62 - $61.64 $320,921 - $383,215
6,217 Added 2.87%
222,641 $12.5 Million
Q3 2017

Nov 08, 2017

BUY
$58.67 - $63.13 $12.7 Million - $13.7 Million
216,424
216,424 $13.9 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $288B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Cannell & Co. Portfolio

Follow Cannell & Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cannell & Co., based on Form 13F filings with the SEC.

News

Stay updated on Cannell & Co. with notifications on news.